Related Experiment Video
Updated: Oct 30, 2025

Calcification of Vascular Smooth Muscle Cells and Imaging of Aortic Calcification and Inflammation
Published on: May 31, 2016
Thoracic Aortic Calcification and Pre-Clinical Hypertension by New 2017 ACC/AHA Hypertension Guidelines
Ya-Ting Jan1,2,3,4, Pei-Shan Tsai1,2,3,4, Chris T Longenecker5
1Department of Biomedical Imaging and Radiological Sciences, National Yang Ming Chiao Tung University, Taipei 112, Taiwan.
Insights
The 2017 hypertension guidelines reveal thoracic aortic calcification (TAC) risk increases even with elevated blood pressure, not yet classified as hypertension. This finding highlights the importance of early blood pressure management for cardiovascular health.
Area of Science:
- Cardiology
- Radiology
- Preventive Medicine
Background:
- The 2017 ACC/AHA hypertension guidelines lowered thresholds for hypertension (HTN) to enable earlier cardiovascular disease (CVD) prevention.
- Thoracic aortic calcification (TAC) is a novel marker for vascular aging and aortic degeneration, but its association with HTN stages under the 2017 guidelines is not well-defined.
Purpose of the Study:
- To investigate the relationship between different stages of hypertension, as defined by the 2017 ACC/AHA guidelines, and thoracic aortic calcification (TAC) in asymptomatic individuals.
- To identify independent risk factors for TAC and establish predictive blood pressure cutoffs for TAC presence.
Main Methods:
- 3022 asymptomatic individuals were categorized into normal blood pressure (NBP), elevated blood pressure (EBP), stage 1 (S1) HTN, and stage 2 (S2) HTN based on 2017 ACC/AHA guidelines.
- Coronary artery calcification and TAC metrics (Agatston score, plaque volume, mean density) were assessed using multi-detector computed tomography.
- Multivariate logistic regression was used to determine independent risk factors for TAC.
Main Results:
- A significant, graded increase in TAC metrics was observed from elevated blood pressure (EBP) through stages 1 and 2 HTN compared to normal blood pressure (NBP).
- Independent risk factors for higher TAC included older age (>50 years), S1/S2 HTN, diabetes, and chronic kidney disease (<60 mL/min/1.73 m²).
- Optimal blood pressure cutoffs for TAC presence (excluding known CVD/medication) were 121 mmHg systolic, 74 mmHg diastolic, and 45 mmHg pulse pressure.
Conclusions:
- Thoracic aortic calcification (TAC) risk begins at the elevated blood pressure stage, preceding formal hypertension diagnosis under the 2017 ACC/AHA guidelines.
- The findings underscore the significance of managing elevated blood pressure for preventing aortic calcification and related CVD.
- Early identification and management of elevated blood pressure are crucial for mitigating TAC risk.
Abstract:
The recently revised 2017 American College of Cardiology/American Heart Association (ACC/AHA) hypertension (HTN) guidelines employ a lower blood pressure threshold to define HTN, aiming for earlier prevention of HTN-related cardiovascular diseases (CVD). Thoracic aortic calcification (TAC), a new surrogate marker of aging and aortic medial layer degeneration, and different stages of HTN, according to the 2017 ACC/AHA HTN guidelines, remain unknown. We classified 3022 consecutive asymptomatic individuals enrolled into four HTN categories using the revised 2017 ACC/AHA guidelines: normal blood pressure (NBP), elevated blood pressure (EBP), and stage 1 (S1) and stage 2 (S2) HTN. The coronary artery calcification score and TAC metrics (total Agaston TAC score, total plaque volume (mm3), and mean density (Hounsfield units, HU)) were measured using multi-detector computed tomography. Compared to NBP, a graded and significant increase in the TAC metrics was observed starting from EBP and S1 and S2 HTN, using the new 2017 ACC/AHA guidelines (NBP as reference; all trends: p < 0.001). These differences remained consistent after being fully adjusted. Older age (>50 years), S1 and S2 HTN, prevalent diabetes, and chronic kidney disease (<60 mL/min/1.73 m2) are all independently contributing factors to higher TAC risk using multivariate stepwise logistic regressions (all p ≤ 0.001). The optimal cutoff values of systolic blood pressure, diastolic blood pressure, and pulse pressure were 121, 74, and 45 mmHg, respectively, for the presence of TAC after excluding subjects with known CVD and ongoing HTN medication treatment. Our data showed that the presence of TAC starts at a stage of elevated blood pressure not categorized as HTN from the updated 2017 ACC/AHA hypertension guidelines.
Related Concept Videos
Hypertension I: Introduction
Hypertension III: Clinical Manifestations and Diagnostic Studies
Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT
Hypertension II: Pathophysiology
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests
Hypertension and Regulation of Blood Pressure

